Hepatology

This study focused on eGDR, a widely accessible proxy for insulin sensitivity derived from waist circumference, hypertension status, and HbA1c levels.

Key findings showed a clear, stepwise increase in risk of complications, including heart failure, stroke, and cardiac arrest, as liver fibrosis scores rose.

In patients with advanced chronic liver disease, several factors such as diet, changes in gut bacteria, and disruption of the gut–vascular barrier can lead to altered levels of TMA and TMAO.

Discover how SGLT-2 inhibitors are linked with reduced risk of serious liver events in cirrhosis patients.

The study highlights stark contrasts in ACLF triggers across regions: HBV predominates in Eastern countries such as China, while alcohol is the main culprit in the West.

Discover a study revealing how subclinical liver fibrosis, measured by FIB-4, predicts increased mortality risk in coronary artery disease patients.

While other machine learning models like MoRAL-AI and TRAIN-AI have also shown promise, TRIUMPH distinguishes itself through its robust generalisability.

While the primary outcome, a ≥10% reduction in α-SMA, was reached in 29% of ReFerm® recipients versus 14% in the control group, the difference was not statistically significant.